Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously

Int J Antimicrob Agents. 2018 Sep;52(3):385-389. doi: 10.1016/j.ijantimicag.2018.06.006. Epub 2018 Jun 12.

Abstract

Background: Extensively-drug-resistant bacteria (XDRB) have emerged as a major source of resistance. Hospitalization abroad seems to be the major risk factor associated with carriage, and numerous reports have warned about the risk of in-hospital transmission. However, little is known regarding possible community transmission.

Methods: A retrospective matched case-control study was conducted in a Parisian teaching hospital, which included patients admitted to hospital with a history of travel abroad over the preceding 12 months. Each XDRB carrier at admission (case) was matched with two non-carriers (controls) hospitalized in the same ward and admitted during the same month.

Aim: To describe and identify risk factors associated with XDRB carriage at admission.

Findings: Forty-six cases and 92 controls were enrolled. The results of univariate and multi-variate analyses showed that health repatriation was the only factor associated with a higher risk of carrying XDRB (odds ratio 3.22, 95% confidence interval 1.23-7.84; P=0.01). Surprisingly, one-third of the study population had not been hospitalized abroad within the preceding 12 months. The most frequently identified XDRB species were Escherichia coli (36%), Enterococcus spp. (17%) and Klebsiella pneumoniae (9%), and the most frequently identified enzyme was OXA-48 (36%).

Conclusion: In this retrospective study, health repatriation was the only risk factor for XDRB carriage identified at admission. Furthermore, the data suggest community-onset transmission. Therefore, there is an urgent need to conduct studies in high-risk countries to identify the risk factors associated with community carriage.

Keywords: Carbapenemase-producing Enterobacteriaceae; Travel abroad; Vancomycin-resistant Enterococcus spp.

MeSH terms

  • Carbapenem-Resistant Enterobacteriaceae / drug effects
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification*
  • Case-Control Studies
  • Communicable Diseases, Imported / epidemiology*
  • Communicable Diseases, Imported / therapy
  • Communicable Diseases, Imported / transmission*
  • Drug Resistance, Multiple, Bacterial
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / microbiology
  • Enterobacteriaceae Infections / therapy
  • Enterobacteriaceae Infections / transmission*
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli Proteins / genetics
  • Female
  • Gram-Positive Bacterial Infections / epidemiology*
  • Gram-Positive Bacterial Infections / microbiology
  • Gram-Positive Bacterial Infections / therapy
  • Gram-Positive Bacterial Infections / transmission*
  • Hospitalization / statistics & numerical data
  • Humans
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / genetics
  • Male
  • Middle Aged
  • Retrospective Studies
  • Travel
  • Vancomycin-Resistant Enterococci / drug effects
  • Vancomycin-Resistant Enterococci / isolation & purification*
  • beta-Lactamases / genetics

Substances

  • Escherichia coli Proteins
  • beta-Lactamases
  • beta-lactamase OXA-48, E coli